secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001193125-24-005633
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR Therapeutics to effect 1-for-25 reverse stock split on Jan 12, 2024
----------------------------------------------------------------------------

- Reverse stock split of 1-for-25 effective at 12:01 a.m. ET on Jan 12, 2024.
- Outstanding shares reduce from approx. 74.9M to approx. 3.0M; authorized shares cut from 1B to 40M.
- Par value unchanged; no fractional shares issued, cash paid for fractional interests.
- Trading on Nasdaq on split-adjusted basis begins at market open Jan 12; new CUSIP 28202V207 for common.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000119312524005633/0001193125-24-005633-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000119312524005633/d435653d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-005633

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer